NASDAQ : AVTX

Avalo Therapeutics, Inc. — Earnings Estimates

$18.53 USD

$0.48 (2.66%)

Volume
1.15M
Average Volume
2.02M
Market Capitalization
$209.28M
P/E Ratio
-3.18
Dividend Yield
0.00%
Price Target
$45.00
Year High
$24.27
Year Low
$7.87
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$7.66

Annual earnings financials

AVTX financial data with annual/quarterly toggle

AVTX GAAP EPS - Annual & Quarterly

AVTX Sales Revenue - Annual & Quarterly

AVTX Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

AVTX Estimated and Actual Revenue by Quarter
AVTX Estimated and Actual EPS by Quarter
AVTX Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
AVTX Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -16.22M -16.22M -16.22M - - -
2027-09-30 0 -13.47M -13.47M -13.47M - - -
2027-06-30 0 -12.03M -12.03M -12.03M - - -
2027-03-31 0 -10.59M -10.59M -10.59M - - -
2026-12-31 0 -12.32M -12.32M -12.32M - - -
2026-09-30 0 -13.92M -6.13M -9.94M - - -
AVTX Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 2 -0.80667 -0.80667 -0.80667
2027-09-30 0 - - - 2 -0.67 -0.67 -0.67
2027-06-30 0 - - - 2 -0.59833 -0.59833 -0.59833
2027-03-31 0 - - - 3 -0.52667 -0.52667 -0.52667
2026-12-31 0 - - - 3 -0.61273 -0.61273 -0.61273
2026-09-30 0 - - - 7 -0.69236 -0.30497 -0.49454